Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
D000096:Acetone / Q000652:urine; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase; D000963:Antimetabolites / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases; D001797:Blood Protein Electrophoresis; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007958:Leukocyte Count; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*; D014557:Urobilin / Q000652:urine
D000963:Antimetabolites; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D009281:Naphthalenes; D014280:Triglycerides; D000096:Acetone; D014557:Urobilin; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase